Toxic and metabolic effect of sodium butyrate on SAS tongue cancer cells: Role of cell cycle deregulation and redox changes

Toxicology

Volumn 223, Issue 3, 2006, Pages 235-247

  Jeng, Jiiang Huei ^a   Kuo, Mark Yen Ping ^a   Lee, Po Hsuen ^b   Wang, Ying Jan ^c   Lee, Mon Ying ^a   Lee, Jang Jaer ^a   Lin, Bor Ru ^a   Tai, Tseng Fang ^a   Chang, Mei Chi ^b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Antioxidants; Apoptosis; Butyrate; Cell cycle; Cytotoxicity; Reactive oxygen species

Indexed keywords

ACETYLCYSTEINE; BUTYRIC ACID; CATALASE; CYCLIN B1; CYCLIN DEPENDENT KINASE 1; DIMETHYLTHIOUREA; MESSENGER RNA; PROTEIN P21; PROTEIN TYROSINE PHOSPHATASE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL POPULATION; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; MITOSIS INHIBITION; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TONGUE CANCER;

APOPTOSIS; BUTYRATES; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; FREE RADICAL SCAVENGERS; GENE EXPRESSION; HUMANS; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; TONGUE NEOPLASMS;

EID: 33744788610     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2006.04.033     Document Type: Article

References (48)

1. Abrahamse S.L., Pool-Zobel B.L., and Rechkemmer G. Potential of short chain fatty acids to modulate the induction of DNA damage and changes in the intracellular calcium concentration by oxidative stress in isolated rat distal colon cells. Carcinogenesis 20 (1999) 629-634
2. Blottiere H.M., Buecher B., Galmiche J.P., and Cherbut C. Molecular analysis of the effect of short-chain fatty acids on intestinal cell proliferation. Proc. Nutr. Soc. 62 (2003) 101-106
3. Chang H.H., Guo M.K., Kasten F.H., Chang M.C., Huang G.F., Wang Y.L., Wang R.S., and Jeng J.H. Stimulation of glutathione depletion ROS production and cell cycle arrest of dental pulp cells and gingival epithelial cells by HEMA. Biomaterials 26 (2005) 745-753
4. Chang J.Q., Hsieh-Li H.M., Jong Y.J., Wang N.M., Tsai C.H., and Li H. Treatment of spinal muscular atrophy by sodium butyrate. Proc. Natl. Acad. Sci. USA 98 (2001) 9808-9813
5. Chang M.C., Uang B.J., Wu H.L., Lee J.J., Hahn L.J., and Jeng J.H. Inducing the cell cycle arrest and apoptosis of oral KB carcinoma cells by hydroxychavicol: roles of glutathione and reactive oxygen species. Br. J. Pharmacol. 135 (2002) 619-630
6. Chang M.C., Wu H.L., Lee J.J., Lee P.H., Chang H.H., Hahn L.J., Lin B.R., Chen Y.J., and Jeng J.H. The induction of prostaglandin E2 production, interleukin-6 production, cell cycle arrest and cytotoxicity in primary oral keratinocytes and KB cancer cells by areca nut ingredients is differentially regulated by MEK/ERK activation. J. Biol. Chem. 279 (2004) 50673-50683
7. Chen P.H., Ko Y.C., Yang Y.H., Lin Y.C., Shieh T.Y., Chen C.H., and Tsai C.C. Important prognostic factors of long-term orpharyngeal carcinoma survivors in Taiwan. Oral Oncol. 40 (2004) 847-855
8. Chenais B., Andriollo M., Guiraud P., Belhoussine R., and Jeannesson P. Oxidative stress involvement in chemically induced differentiation of K562 cells. Free Radical Biol. Med. 28 (2000) 18-27
9. Davie J.R. Inhibition of histone deacetylase activity by butyrate. J. Nutr. 133 (2003) 2485S-2493S
10. DOH Report, Department of Health, Taiwan, Republic of China, Cancer Registration Report; 2004.
11. Ebert M.N., Klinder A., Peters W.H., Schaferhenrich A., Sendt W., Schelle J., and Pool-Zobel B.L. Expression of glutathione S-transferase (GSTs) in human colon cells and inducibility of GSTM2 by butyrate. Carcinogenesis 24 (2003) 1637-1644
12. Furukawa Y., Iwase S., Terui Y., KikuchiJ, Sakai T., Nakamura M., Kitagawa S., and Kitagawa M. Transcriptional activation of the cdc2 gene is ssociated with Fas-induced apoptosis of human hematopoietic cells. J. Biol. Chem. 271 (1996) 28469-28477
13. Giardina C., and Inan M.S. Nonsteroidal anti-inflammatory drugs, short-chain fatty acids and reactive oxygen metabolism in human colorectal cancer cells. Biochim. Biophys. Acta 1401 (1998) 277-288
14. Giardina C., Boulares H., and Inan M.S. NSAIDs and butyrate sensitize a human colorectal cancer cell line to TNF-alpha and Fas ligation: the role of reactive oxygen species. Biochim. Biophys. Acta 1448 (1999) 425-438
15. Gillenwater A., Zou C.P., Zhong M., and Lotan R. Effects of sodium butyrate on growth, differentiation, and apoptosis in head and neck squamous carcinoma cell lines. Head Neck 22 (2000) 247-256
16. Harrison L.E., Wang Q.M., and Studzinski G.P. Butyrate-induced G2/M block in Caco-2 colon cancer cells is associated with decreased p34cdc2 activity. Proc. Soc. Exp. Biol. Med. 222 (1999) 150-156
17. Hashimoto O., Ueno T., Kimura R., Ohtsubo M., Nakamura T., Koga H., Torimura T., Uchida S., Yamashita K., and Sata M. Inhibition of proteasom-dependent degradation of Weel in G2 arrested Hep3B cells by TGFbetal. Mol. Carcinog. 36 (2003) 171-182
18. Hockenbery D.M., Oltvai Z.N., Yin X.M., Milliman C.L., and Korsmeyer S.I. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75 (1993) 241-251
19. Hofmanova J., Vaculova A., Lojek A., and Kozubik A. Interaction of polyunsaturated fatty acids and sodium butyrate during apoptosis in HT-29 human colon adenocarcinoma cells. Eur. J. Nutr. (2004) 1-12
20. IARC. IARC monographs on the evaluation of carcinogenic risks to humans. Betel-Quid and Areca-Nut Chewing and Some Areca-Nut-Derived Nitrosamines vol. 85 (2004), IARC, WHO
21. Jeng J.H., Chan C.P., Ho Y.S., Lan W.H., Hsieh C.C., and Chang M.C. Effects of butyrate and propionate on the adhesion, growth, cell cycle kinetics and protein synthesis of cultured human gingival fibroblasts. J. Periodontol. 70 (1999) 1435-1442
22. Jeng J.H., Ho Y.S., Chan C.P., Wang Y.J., Hahn L.J., Lei D., Hsu C.C., and Chang M.C. Areca nut extract up-regulates prostaglandin production, cyclooxygenase-2 mRNA and protein expression of human oral keratinocytes. Carcinogenesis 21 (2000) 1365-1370
23. Jeng J.H., Wang Y.J., Chiang B.L., Lee P.H., Chan C.P., Ho Y.S., Wang T.M., Lee J.J., Hahn L.J., and Chang M.C. Roles of keratinocyte inflammation in oral cancer: regulating the prostaglandin E2, interleukin-6 and TNF-alpha production of oral epithelial cells by areca nut extract and arecoline. Carcinogenesis 24 (2003) 1301-1315
24. Jeng J.H., Wang Y.J., Chang W.H., Wu H.L., Li C.H., Uang B.J., Kang J.J., Lee J.J., Hahn L.J., Lin B.R., and Chang M.C. Reactive oxygen species are crucial for hydroxychavicol toxicity toward KB epithelial cells. Cell. Mol. Life Sci. 61 (2004) 83-96
25. Joensuu T., and Mester J. Inhibition of cell cycle progression by sodium butyrate in normal rat kidney fibroblasts is altered by expression of the adenovirus 5 early 1A gene. Biosci. Rep. 14 (1994) 291-300
26. Kinghorn A.D., Su B.N., Jang D.S., Chang L.C., Lee D., Gu J.Q., Carcache-Blanco E.J., Pawlus A.D., Lee S.K., Park E.J., Cuendet M., Gills J.J., Bhat K., Park H.S., Mata-Greenwood E., Song L.L., Jang M., and Pezzuto J.M. Natural inhibitors of carcinogenesis. Planta Med. 70 (2004) 691-705
27. Kok S.H., Cheng S.J., Hong C.Y., Lee J.J., Lin S.K., Kuo Y.S., Chiang C.P., and Kuo M.Y. Norcantharidin-induced apoptosis in oral cancer cells is associated with an increase of proapoptotic to antiapoptotic protein ratio. Cancer Lett. 217 (2005) 43-52
28. Kovacs A.F. Intra-arterial induction high-dose chemotherapy with cisplatin for oral and oropharyngeal cancer: long-term results. Br. J. Cancer 90 (2004) 1323-1328
29. Krause K., Masner M., Reinhard W., Haugwitz U., Dohna C.L., Mossner J., and Engeland K. The tumor suppressor protein p53 can repress transcription of cyclin B. Nucleic Acid Res. 28 (2000) 4410-4418
30. Lei D., Chan C.P., Wang Y.J., Wang T.M., Lin B.R., Huang C.H., Lee J.J., Chen H.M., Jeng J.H., and Chang M.C. Antioxidative and antiplatelet effects of aqueous inflorescence Piper betle extract. J. Agric. Food Chem. 51 (2003) 2083-2088
31. Li X., Mikkelsen J.M., Mortensen B., Winberg J.O., and Huseby N.E. Butyrate reduces liver metastasis of rat colon carcinoma cells in vivo and resistance to oxidative stress in vitro. Clin. Exp. Metastasis 31 (2004) 331-338
32. Louis M., Rosato R.R., Brault L., Osbild S., Battaglia E., Yang X.H., Grant S., and Bagrel D. The histone deacetylase inhibitor sodium butyrate induces breast cancer cell apoptosis through diverse cytotoxic actions including glutathione depletion and oxidative stress. Int. J. Oncol. 25 (2004) 1701-1711
33. Lupton J.R. Microbial degradation products influence colon cancer risk: the butyrate controversy. J. Nutr. 34 (2004) 479-482
34. Mikkelsen I.M., Mortensen B., Laperche Y., and Huseby N.E. The expression of gamma-glutamyltransferase in rat colon carcinoma cells is distinctly regulated during differentiation and oxidative stress. Mol. Cell. Biochem. 232 (2002) 87-95
35. Miller S.J. Cellular and Physiological effects of short-chain fatty acids. Mini Rev. Med. Chem. 4 (2004) 839-845
36. Niederman R., Buyle-Bodin Y., Lu B.Y., Robinson P., and Naleway C. Short-chain carboxylic acid concentration in human gingival crevicular fluid. J. Dent. Res. 76 (1997) 575-579
37. Pollanen M.T., Overman D.O., and Salonen J.L. Bacterial metabolites sodium butyrate and propionate inhibit epithelial cell growth in vitro. J. Periodontol. Res. 32 (1997) 326-334
38. Ranganna K., Yousefipour Z., Yatsu F.M., Milton S.Q., and Hayes B.E. Gene expression profile of butyrate-inhibited vascular smooth muscle cell proliferation. Mol. Cell. Biochem. 254 (2003) 21-36
39. Ren H., Musch M.W., Kojima K., Boone D., Ma A., and Chang E.B. Short-chain fatty acids induce intestinal epithelial heat shock protein 2 expression in rats and IEC 18 cells. Gastroenterology 121 (2001) 631-639
40. WAF1/CIP1 down-regulation in synergistic antileukemic interactions between the histone deacetylase inhibitor sodium butyrate and flavopiridol. Mol. Pharmacol. 65 (2004) 571-581
41. Rosignoli P., Fabiani R., De Bartolomeo A., Spinozzi F., Agea E., Pelli M.A., and Morozzi G. Protective activity of butyrate on hydrogen peroxide-induced DNA damage in isolated human colonocytes and HT29 tumour cells. Carcinogenesis 22 (2001) 1675-1680
42. Scheppach W., and Weiler F. The butyrate story: old wine in new bottles. Curr. Opin. Clin. Nutr. Metab. Care 7 (2004) 563-567
43. Singer R.E., and Buckner B.A. Butyrate and propionate: important components of toxic dental plaque extracts. Infect. Immun. 32 (1981) 458-463
44. Uematsu H., Sato N., Hossain M.Z., Ikeda T., and Hoshino E. Degradation of arginine and other amino acids by butyrate-producing asaccharolytic anaerobic Gram-positive rods in periodontal pockets. Arch. Oral Biol. 48 (2003) 423-429
45. Vernia P., Fracasso P.L., Casale V., Villotti Q., Marcheggiano A., Stigliano V., Pinnaro P., Bagnardi V., and Caprilli R. Topical butyrate for acute radiation proctitis: randomized, crossover trial. Lancet 356 (2000) 1232-1235
46. Williams E.A., Coxhead J.M., and Mathers J.C. Anti-cancer effects of butyrate: use of micro-array technology to investigate mechanisms. Proc. Nutr. Soc. 62 (2003) 107-115
47. Yano S., and Tierney D.E. Butyrate increases catalase activity and protects rat pulmonary artery smooth muscle cells against hyperoxia. Biochem. Biophys. Res. Commun. 164 (1989) 1143-1148
48. 2, hypochlorite, superoxide and hydroxyl radicals. Food Chem. Toxicol. 40 (2002) 1403-1413